Completed NA INTERVENTIONAL 2-arm NCT03809793

Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?

Sponsor: Diabetes UK

Interventions Acipimox 250 MG Continuous Glucose Monitor DXA Exercise Program Hyperinsulinaemic Euglycaemic Clamp MRI Muscle Biopsies VO2 Max

Updated 8 times since 2019 Last updated: Dec 29, 2023 Started: Jan 6, 2020 Primary completion: Jul 31, 2023 Completion: Jul 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pre-diabetes and is currently completed. Diabetes UK leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2024 — Jul 2024 [monthly]

Completed NA

Status: Suspended → Completed
Oct 2021 — Feb 2024 [monthly]

Suspended NA

Status: Recruiting → Suspended
Jan 2021 — Oct 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Mar 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2020 — Mar 2020 [monthly]

Not Yet Recruiting NA
Feb 2019 — Feb 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diabetes UK
Liverpool John Moores University
Liverpool University Hospitals NHS Foundation Trust
Royal Liverpool University Hospital

Data source: Liverpool John Moores University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liverpool, United Kingdom